SPONSOR
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Total Trials
2
Recruiting
2
Phases
Phase 2
Cancer Institute and Hospital, Chinese Academy of Medical Sciences is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Chemoradiotherapy, Siewert Type II Adenocarcinoma of Esophagogastric Junction.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Cancer Institute and Hospital, Chinese Academy of Medical Sciences
How many clinical trials has Cancer Institute and Hospital, Chinese Academy of Medical Sciences sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences, of which 2 are actively recruiting participants. These trials cover conditions including Chemoradiotherapy, Siewert Type II Adenocarcinoma of Esophagogastric Junction. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Cancer Institute and Hospital, Chinese Academy of Medical Sciences research focus on?
Cancer Institute and Hospital, Chinese Academy of Medical Sciences clinical trials span Chemoradiotherapy, Siewert Type II Adenocarcinoma of Esophagogastric Junction. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Cancer Institute and Hospital, Chinese Academy of Medical Sciences clinical trial?
To participate in a Cancer Institute and Hospital, Chinese Academy of Medical Sciences trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Cancer Institute and Hospital, Chinese Academy of Medical Sciences trials with current recruitment status updated daily.
Clinical Trials by Cancer Institute and Hospital, Chinese Academy of Medical Sciences
NCT06667622 Phase 2
Recruiting
Sodium Glycididazole Reduces the Adverse Reactions of Concurrent Chemoradiotherapy
Chemoradiotherapy
NCT06644352
Recruiting
Right Versus Left Thoracic Surgical Approaches for Siewert II Gastroesophageal Junction Adenocarcinoma
Siewert Type II Adenocarcinoma of Esophagogastric Junction
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology